文献速递胸部肿瘤放疗

双肺移植后早期肺癌的立体定向消融放疗

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation.
PubMed 文献 · Radiat Oncol · 2018-08-07

本文报告一例因晚期肺气肿行双肺移植8年后,供体肺发生IB期腺癌的病例。患者因慢性移植肺功能障碍导致肺功能严重受损而无法手术,经讨论后行根治性全剂量SABR,耐受良好,仅出现一次经治疗缓解的亚急性毒性;治疗后15个月无复发证据,肺功能未偏离SABR前基线。作者认为,对于既往双肺移植、医学上无法手术的早期原发性肺腺癌,SABR似乎可行。

要点

  • 双肺移植后供体肺发生原发性肺癌罕见,本例为移植8年后供体肺IB期腺癌。
  • 患者因慢性移植肺功能障碍致肺功能严重受损,无法手术。
  • 全剂量SABR耐受良好,治疗后15个月无复发,肺功能未偏离基线。

核心结论

  • 作者认为,对于既往双肺移植、医学上无法手术的早期原发性肺腺癌,SABR似乎可行。

研究设计与样本

  • 个案报告,报告一例双肺移植后供体肺发生早期肺腺癌并接受SABR的患者。
  • 患者因晚期肺气肿行双肺移植,8年后供体肺发生IB期腺癌。
  • 患者因慢性移植肺功能障碍导致肺功能严重受损,无法手术。

主要发现

  • 经与患者讨论后,以根治性意图给予全剂量SABR。
  • 患者耐受良好,出现一次亚急性毒性,经治疗缓解。
  • 治疗后15个月无复发证据,肺功能未偏离SABR前基线。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Development of primary lung cancer in donor lung post-lung transplantation is very rare, with few described cases. The safety of stereotactic ablative radiotherapy (SABR) for early-stage lung cancer arising from donor lung is unclear. CASE PRESENTATION: Herein, we present a case of a patient with a Stage IB adenocarcinoma arising from donor lung 8 years post-double lung transplantation, which was performed due to advanced emphysema. The patient was ineligible for surgical management due to chronic lung allograft dysfunction, which significantly compromised pulmonary function. Full dose SABR was delivered with curative intent after a discussion with the patient. The patient tolerated the treatment well, with one episode of subacute toxicity that resolved with treatment. There was no evidence of recurrence at 15 months post-treatment and the patient's pulmonary function did not deviate from the pre-SABR baseline. CONCLUSIONS: SABR appears feasible for medically-inoperable early-stage primary lung adenocarcinoma in the setting of previous double-lung transplantation.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Chen H, Tikkanen J, Boldt RG, et al. Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation. Radiat Oncol. 2018. PMID: 30086765. doi:10.1186/s13014-018-1089-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。